| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Revenue | $988M (YoY +10%) | $1,030M (YoY +10%) | +4.3% QoQ acceleration |
| EPS | $1.93 (YoY +14%) | $2.47 (YoY +20%) | +28% QoQ surge |
| Operating Income | $205M (20.8% margin) | $217M (21.0% margin) | +20 bps margin expansion |
| Free Cash Flow | $147M (100% conversion) | Not disclosed | Metric disappeared |
| Semi Revenue | $415M (YoY +10%) | $435M (YoY +9%) | YoY deceleration |
| E&P Revenue | $289M (YoY +25%) | $303M (YoY +19%) | 600 bps YoY deceleration |
| Chemistry Sales ex-FX | +10% YoY | +16% YoY | +600 bps acceleration |
| Gross Margin | 46.6% | 46.4% | 20 bps compression |
| Net Leverage Ratio | 3.9x | 3.7x | 20 bps improvement |
| Operating Cash Flow | $147M quarterly | $645M full year | 21% YoY growth |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.